MoneyWorks4Me

NGL Fine-Chem - Quaterly Results

12 Aug 2024 Evaluate
The sales for the June 2024 quarter moved up 27.38% to Rs. 880.34 millions as compared to Rs. 691.14 millions during the corresponding quarter last year.Profit for the quarter ended June 2024 increased merely by0.27% to Rs. 78.26  millions from Rs. 78.05 millions.OP of the company witnessed a marginal growth to 125.85 millions from 114.03 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 880.34 691.14 27.38 880.34 691.14 27.38 3289.73 2750.52 19.60
Other Income 62.67 38.02 64.83 62.67 38.02 64.83 159.01 76.12 108.89
PBIDT 125.85 114.03 10.37 125.85 114.03 10.37 601.94 356.96 68.63
Interest 4.43 2.43 82.30 4.43 2.43 82.30 13.38 11.97 11.78
PBDT 121.42 111.60 8.80 121.42 111.60 8.80 588.56 344.99 70.60
Depreciation 21.40 19.99 7.05 21.40 19.99 7.05 81.48 78.99 3.15
PBT 100.02 91.61 9.18 100.02 91.61 9.18 507.08 266.00 90.63
TAX 21.76 13.56 60.47 21.76 13.56 60.47 121.89 64.81 88.07
Deferred Tax 3.51 1.72 104.07 3.51 1.72 104.07 7.76 -7.30 -206.30
PAT 78.26 78.05 0.27 78.26 78.05 0.27 385.19 201.19 91.46
Equity 30.89 30.89 0.00 30.89 30.89 0.00 30.89 30.89 0.00
PBIDTM(%) 14.30 16.50 -13.35 14.30 16.50 -13.35 18.30 12.98 40.99
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..